Rynki

Twoje finanse

Biznes

Forum

SOPHARMA AD: Notification for buy-back shares

Spis treści:

1. REPORT

reklama

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current report 230 buy back espi.pdf  (REPORT)

przewiń, aby zobaczyć całą tabelę
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 230 / 2023
Date of issue: 2023-12-14
Short name of the issuer
SOPHARMA AD
Subject
Notification for buy-back shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:

Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 13, 2023 the Company bought 184 000 (one hundred and eighty-four thousand) own shares representing 0.107% of the share capital of the Company, at a total value of BGN 1 122 400 on the Bulgarian Stock Exchange, the average price per share was BGN 6,10.
The total number of treasury shares after this transaction is 14,229,188 representing 8.244% of the share capital of the Company.
Annexes
File Description
Current report 230 buy back espi.pdfCurrent report_230_buy back_espi.pdf Notification for buy-back shares

przewiń, aby zobaczyć całą tabelę
SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

przewiń, aby zobaczyć całą tabelę
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-12-14 Ognian Donev Executive Director
Źródło: Komunikaty spółek (ESPI)
powiązane
polecane
najnowsze
popularne
najnowsze
bankier na skróty